Functional hydrogels for the treatment of myocardial infarction
Source abstract
Abstract
Abstract Myocardial infarction (MI) is a major disease posing a significant threat to human health, as it leads to necrosis of numerous cardiomyocytes (CMs), left ventricle dilation, and cardiac dysfunction, ultimately resulting in heart failure. Owing to the shortage of heart donors and the shortcomings of current clinical treatment methods, significant resources have been dedicated to developing platforms for cardiac tissue engineering, including functional hydrogels. Herein, we review variations in the myocardial microenvironment and the effects of functional hydrogel systems that are designed to support and mimic this microenvironment during cardiac repair following MI. Specifically, we provide an overview of recent functional hydrogels designed for cardiac tissue engineering. These include matrix metalloproteinase-responsive hydrogels, reactive oxygen species-scavenging hydrogels and immunomodulatory hydrogels, which can reverse the adverse myocardial microenvironment. Additionally, we describe conductive hydrogels that can reconstruct electrical signal conduction within infarct areas, vascularized hydrogels that promote the repair of cardiac function, and 3D-printed hydrogels, which can achieve personal customized cardiac tissue via printing of intact cardiac structures, thus addressing the current shortage of heart donors.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Shi, H. P. et al. Microneedle-mediated gene delivery for the treatment of ischemic myocardial disease. Sci. Adv. 6, eaaz3621 (2020).10.1126/sciadv.aaz3621 ↗
2. Wu, Y. et al. Release of VEGF and BMP9 from injectable alginate based composite hydrogel for treatment of MI. Bioact. Mater. 6, 520–528 (2021).10.1016/j.bioactmat.2020.08.031 ↗
3. Lin, X. et al. A viscoelastic adhesive epicardial patch for treating MI. Nat. Biomed. Eng. 3, 632–643 (2019).10.1038/s41551-019-0380-9 ↗
4. Fiedler, J. & Thum, T. MicroRNAs in MI. Arterioscler Thromb. Vasc. Biol. 33, 201–205 (2013).10.1161/ATVBAHA.112.300137 ↗
5. Sepantafar, M. et al. Stem cells and injectable hydrogels: synergistic therapeutics in myocardial repair. Biotechnol. Adv. 34, 362–379 (2016).10.1016/j.biotechadv.2016.03.003 ↗
6. Pena, B. et al. Injectable hydrogels for cardiac tissue engineering. Macromol. Biosci. 18, 1800079 (2018).10.1002/mabi.201800079 ↗
7. Heallen, T. R. & Martin, J. F. Heart repair via cardiomyocyte-secreted vesicles. Nat. Biomed. Eng. 2, 271–272 (2018).10.1038/s41551-018-0239-5 ↗
8. Hashimoto, H., Olson, E. N. & Bassel-Duby, R. Therapeutic approaches for cardiac regeneration and repair. Nat. Rev. Cardiol. 15, 585–600 (2018).10.1038/s41569-018-0036-6 ↗
9. Marban, E. A mechanistic roadmap for the clinical application of cardiac cell therapies. Nat. Biomed. Eng. 2, 353–361 (2018).10.1038/s41551-018-0216-z ↗
10. Zhang, Y. et al. A collagen hydrogel loaded with HDAC7-derived peptide promotes the regeneration of infarcted myocardium with functional improvement in a rodent mode. Acta Biomater. 86, 223–234 (2019).10.1016/j.actbio.2019.01.022 ↗
11. Li, H. K. et al. Folic acid-derived hydrogel enhances the survival and promotes therapeutic efficacy of iPS cells for acute MI. ACS Appl. Mater. Interfaces 10, 24459–24468 (2018).10.1021/acsami.8b08659 ↗
12. Wu, T. L. et al. Coadministration of an adhesive conductive hydrogel patch and an injectable hydrogel to treat MI. ACS Appl. Mater. Interfaces 12, 2039–2048 (2020).10.1021/acsami.9b17907 ↗
13. Jackman, C. P. et al. Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation. Biomaterials 159, 48–58 (2018).10.1016/j.biomaterials.2018.01.002 ↗
14. Pedron, S. et al. Stimuli responsive delivery vehicles for cardiac microtissue transplantation. Adv. Funct. Mater. 21, 1624–1630 (2011).10.1002/adfm.201002708 ↗
15. Peña, B. et al. Injectable hydrogels for cardiac tissue engineering. Macromol. Biosci. 18, 1800079 (2018).10.1002/mabi.201800079 ↗
16. Camci-Unal, G., Annabi, N., Dokmeci, M. R., Liao, R. & Khademhosseini, A. Hydrogels for cardiac tissue engineering. NPG Asia. Mater. 6, e99 (2014).10.1038/am.2014.19 ↗
17. Nguyen, M. M. et al. Enzyme-responsive nanoparticles for targeted accumulation and prolonged retention in heart tissue after MI. Adv. Mater. 27, 5547–5552 (2015).10.1002/adma.201502003 ↗
18. Kampourides, N. et al. Usefulness of matrix metalloproteinase-9 plasma levels to identify patients with preserved left ventricular systolic function after acute MI who could benefit from eplerenone. Am. J. Cardiol. 110, 1085–1091 (2012).10.1016/j.amjcard.2012.05.049 ↗
19. Zhang, Y. et al. Biomimetic design of mitochondria-targeted hybrid nanozymes as superoxide scavengers. Adv. Mater. 33, 2006570 (2021).10.1002/adma.202006570 ↗
20. Yao, Y. J. et al. ROS-responsive polyurethane fibrous patches loaded with methylprednisolone (MP) for restoring structures and functions of infarcted myocardium in vivo. Biomaterials 232, 119726 (2020).10.1016/j.biomaterials.2019.119726 ↗
21. McMahan, S. et al. Current advances in biodegradable synthetic polymer based cardiac patches. J. Biomed. Mater. Res. 108, 972–983 (2020).10.1002/jbm.a.36874 ↗
22. Li, Y. et al. Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for MI therapy in pigs. Sci. Adv. 7, eabd6740 (2021).10.1126/sciadv.abd6740 ↗
23. Purcell, B. P. et al. Delivery of a matrix metalloproteinase-responsive hydrogel releasing TIMP-3 after MI: effects on left ventricular remodeling. Am. J. Physiol. Heart Circ. Physiol. 315, H814–H825 (2018).10.1152/ajpheart.00076.2018 ↗
24. Creemers, E. E. J. M., Cleutjens, J. P. M., Smits, J. F. M. & Daemen, M. J. A. P. Matrix metalloproteinase inhibition after MI-A new approach to prevent heart failure? Circ. Res. 89, 201–210 (2001).10.1161/hh1501.094396 ↗
25. Wang, K. F. et al. Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute MI. Coron. Artery Dis. 24, 23–28 (2013).10.1097/MCA.0b013e32835aab4a ↗
26. Sun, Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc. Res. 81, 482–490 (2009).10.1093/cvr/cvn333 ↗
27. Spaulding, K. A. et al. Myocardial injection of a thermoresponsive hydrogel with reactive oxygen species scavenger properties improves border zone contractility. J. Biomed. Mater. Res. A 108, 1736–1746 (2020).10.1002/jbm.a.36941 ↗
28. Bloise, N. et al. Engineering immunomodulatory biomaterials for regenerating the infarcted myocardium. Front. Bioeng. Biotech. 8, 292 (2020).10.3389/fbioe.2020.00292 ↗
29. Zhao, G. X. et al. Anisotropic conductive reduced graphene oxide/silk matrices promote post-infarction myocardial function by restoring electrical integrity. Acta Biomater. https://doi.org/10.1016/j.actbio.2021.03.073 (2021).10.1016/j.actbio.2021.03.073 ↗
30. Song, C. et al. An injectable conductive three-dimensional elastic network by tangled surgical-suture spring for heart repair. ACS Nano 13, 14122–14137 (2019).10.1021/acsnano.9b06761 ↗
31. Wang, L. L. et al. Sustained miRNA delivery from an injectable hydrogel promotes cardiomyocyte proliferation and functional regeneration after ischaemic injury. Nat. Biomed. Eng. 1, 983–992 (2017).10.1038/s41551-017-0157-y ↗
32. Wall, S. T., Walker, J. C., Healy, K. E., Ratcliffe, M. B. & Guccione, J. M. Theoretical impact of the injection of material into the myocardium. Circulation 114, 2627–2635 (2006).10.1161/CIRCULATIONAHA.106.657270 ↗
33. Zhu, Y., Matsumura, Y. & Wagner, W. R. Ventricular wall biomaterial injection therapy after MI: advances in material design, mechanistic insight and early clinical experiences. Biomaterials 129, 37–53 (2017).10.1016/j.biomaterials.2017.02.032 ↗
34. Park, S. J. et al. Dual stem cell therapy synergistically improves cardiac function and vascular regeneration following MI. Nat. Commun. 10, 3123 (2019).10.1038/s41467-019-11091-2 ↗
35. Huang, K. et al. An off-the-shelf artificial cardiac patch improves cardiac repair after MI in rats and pigs. Sci. Transl. Med. 12, eaat9683 (2020).10.1126/scitranslmed.aat9683 ↗
36. Gustafson, J. A. et al. Synthesis and characterization of a matrix-metalloproteinase responsive silk-elastinlike protein polymer. Biomacromolecules 14, 618–625 (2013).10.1021/bm3013692 ↗
37. Fonseca, K. B. et al. Enzymatic, physicochemical and biological properties of MMP-sensitive alginate hydrogels. Soft Matter 9, 3283–3292 (2013).10.1039/c3sm27560d ↗
38. Martin, J. R., Patil, P., Yu, F., Gupta, M. K. & Duvall, C. L. Enhanced stem cell retention and antioxidative protection with injectable, ROS-degradable PEG hydrogels. Biomaterials 263, 120377 (2021).10.1016/j.biomaterials.2020.120377 ↗
39. Cheng, H. et al. Sprayable hydrogel dressing accelerates wound healing with combined reactive oxygen species-scavenging and antibacterial abilities. Acta Biomater. 124, 219–232 (2021).10.1016/j.actbio.2021.02.002 ↗
40. Zhou, J. et al. Injectable OPF/graphene oxide hydrogels provide mechanical support and enhance cell electrical signaling after implantation into myocardial infarct. Theranostics 8, 3317–3330 (2018).10.7150/thno.25504 ↗
41. Kim, D. H. et al. Guided three-dimensional growth of functional cardiomyocytes on polyethylene glycol nanostructures. Langmuir 22, 5419–5426 (2006).10.1021/la060283u ↗
42. Madden, L. R. et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc. Natl Acad. Sci. USA 107, 15211–15216 (2010).10.1073/pnas.1006442107 ↗
43. Soler-Botija, C., Galvez-Monton, C., Prat-Vidal, C., Roura, S. & Bayes-Genis, A. Myocardial bioprosthesis: mimicking nature. Drug. Future 38, 475–484 (2013).10.1358/dof.2013.038.07.1980500 ↗
44. Liu, J. et al. Direct 3D bioprinting of cardiac micro-tissues mimicking native myocardium. Biomaterials 256, 120204 (2020).10.1016/j.biomaterials.2020.120204 ↗
45. Lee, A. et al. 3D bioprinting of collagen to rebuild components of the human heart. Science 365, 482–487 (2019).10.1126/science.aav9051 ↗
46. Maral, S. et al. Matrix metalloproteinases 2 and 9 polymorphism in patients with myeloproliferative diseases. Medicine 94, e732 (2015).10.1097/MD.0000000000000732 ↗
47. West, J. B., Watson, R. R. & Fu, Z. X. The honeycomb-like structure of the bird lung allows a uniquely thin blood-gas barrier. Resp. Physiol. Neurobi. 152, 115–118 (2006).10.1016/j.resp.2005.12.009 ↗
48. Noujaim, D., van Golen, C. M., van Golen, K. L., Grauman, A. & Feldman, E. L. N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells. Oncogene 21, 4549–4557 (2002).10.1038/sj.onc.1205552 ↗
49. Wada, C. K. et al. Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors. J. Med. Chem. 45, 219–232 (2002).10.1021/jm0103920 ↗
50. Michaelides, M. R. & Curtin, M. L. Recent advances in matrix metalloproteinase inhibitor research. Curr. Pharm. Des. 5, 787–819 (1999).10.2174/1381612805666230111211438 ↗
51. Eckhouse, S. R. et al. Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental MI. Sci. Transl. Med. 6, 223ra21 (2014).10.1126/scitranslmed.3007244 ↗
52. Zavadzkas, J. A. et al. Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-MI remodeling in mice. Circ. Res. 114, 1435–1445 (2014).10.1161/CIRCRESAHA.114.303634 ↗
53. Carlini, A. S. et al. Enzyme-responsive progelator cyclic peptides for minimally invasive delivery to the heart post-myocardial infarction. Nat. Commun. 10, 1735 (2019).10.1038/s41467-019-09587-y ↗
54. Fan, Z. B. et al. Sustained release of a peptide-based matrix metalloproteinase‑2 inhibitor to attenuate adverse cardiac remodeling and improve cardiac function following MI. Biomacromolecules 18, 2820–2829 (2017).10.1021/acs.biomac.7b00760 ↗
55. Purcell, B. P. et al. Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition. Nat. Mater. 13, 653–661 (2014).10.1038/nmat3922 ↗
56. Fan, C. X. et al. Myocardial-infarction-responsive smart hydrogels targeting matrix metalloproteinase for on-demand growth factor delivery. Adv. Mater. 31, 1902900 (2019).10.1002/adma.201902900 ↗
57. Xu, Q., He, C., Xiao, C. & Chen, X. Reactive oxygen species (Ros) responsive polymers for biomedical applications. Macromol. Biosci. 16, 635–646 (2016).10.1002/mabi.201500440 ↗
58. Huo, M., Yuan, J., Tao, L. & Wei, Y. Redox-responsive polymers for drug delivery: from molecular design to applications. Polym. Chem. 5, 1519–1528 (2014).10.1039/C3PY01192E ↗
59. Wang, W. et al. Rebuilding postinfarcted cardiac functions by injecting TIIA@ PDA nanoparticle-cross-linked ROS-sensitive hydrogels. ACS Appl. Mater. Interfaces 11, 2880–2890 (2018).10.1021/acsami.8b20158 ↗
60. Han, X. X. et al. “Ferrero-like” nanoparticles knotted injectable hydrogels to initially scavenge ROS and lastingly promote vascularization in infarcted hearts. Sci. China Tech. Sci. 63, 2435–2448 (2020).10.1007/s11431-020-1638-0 ↗
61. Ding, J. et al. A reactive oxygen species scavenging and O2 generating injectable hydrogel for MI treatment in vivo. Small 16, 2005038 (2020).10.1002/smll.202005038 ↗
62. Zhu, Y. et al. Reactive oxygen species scavenging with a biodegradable, thermally responsive hydrogel compatible with soft tissue injection. Biomaterials 177, 98e112 (2018).10.1016/j.biomaterials.2018.05.044 ↗
63. Li, J. J. et al. A chitosaneglutathione based injectable hydrogel for suppression of oxidative stress damage in cardiomyocytes. Biomaterials 34, 9071e9081 (2013).10.1016/j.biomaterials.2013.08.031 ↗
64. Liu, Z. Q. et al. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials 33, 3093e3106 (2012).
65. Hao, T. et al. Injectable fullerenol/alginate hydrogel for suppression of oxidative stress damage in brown adipose-derived stem cells and cardiac repair. ACS Nano 11, 5474–5488 (2017).10.1021/acsnano.7b00221 ↗
66. Swirski, F. K. & Nahrendorf, M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat. Rev. Immunol. 18, 733–744 (2018).10.1038/s41577-018-0065-8 ↗
67. Frangogiannis, N. G. et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98, 699–710 (1998).10.1161/01.CIR.98.7.699 ↗
68. Anzai, A. et al. The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes. J. Exp. Med. 214, 3293–3310 (2017).10.1084/jem.20170689 ↗
69. Nikolaos, G. F. The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities. J. Cardiovasc. Pharmacol. 63, 83–84 (2014).10.1097/FJC.0000000000000066 ↗
70. Kobara, M. et al. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice. Cardiovasc. Res. 87, 424–430 (2010).10.1093/cvr/cvq078 ↗
71. Marta, M. T. et al. Local administration of porcine immunomodulatory, chemotactic and angiogenic extracellular vesicles using engineered cardiac scaffolds for myocardial infarction. Bioact. Mater. 6, 3314–3327 (2021).10.1016/j.bioactmat.2021.02.026 ↗
72. Liu, Y. et al. Chitosan hydrogel enhances the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction by alleviating vascular endothelial cell pyroptosis. J. Cardiovasc. Pharmacol. 75, 75–83 (2020).10.1097/FJC.0000000000000760 ↗
73. Shin, E. Y. et al. Adenosine production by biomaterial-supported mesenchymal stromal cells reduces the innate inflammatory response in myocardial ischemia/reperfusion injury. J. Am. Heart Assoc. 7, e006949 (2018).10.1161/JAHA.117.006949 ↗
74. Duan, Y. Y. et al. Unsaturated polyurethane films grafted with enantiomeric polylysine promotes macrophage polarization to a M2 phenotype through PI3K/Akt1/mTOR axis. Biomaterials 246, 120012 (2020).10.1016/j.biomaterials.2020.120012 ↗
75. Liu, G. et al. Enhancement of cardiac function with spleen-specific hydrogel via improving the immune microenvironment after myocardial infarction. J. Biomater. Tiss. Eng. 7, 458–468 (2017).10.1166/jbt.2017.1590 ↗
76. Lv, K. Q. et al. Incorporation of small extracellular vesicles in sodium alginate hydrogel as a novel therapeutic strategy for myocardial infarction. Theranostics 9, 7403–7416 (2019).10.7150/thno.32637 ↗
77. Li, Y. et al. Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs. Sci. Adv. 7, eabd6740 (2021).10.1126/sciadv.abd6740 ↗
78. Zhang, X. P. et al. Artificial apoptotic cells/VEGF-loaded injectable hydrogel united with immunomodification and revascularization functions to reduce cardiac remodeling after myocardial infarction. Nano Today 39, 101227 (2021).10.1016/j.nantod.2021.101227 ↗
79. Hofmann, U. et al. Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 125, 1652–U146 (2012).10.1161/CIRCULATIONAHA.111.044164 ↗
80. Weirather, J. et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ. Res. 115, 55–67 (2014).10.1161/CIRCRESAHA.115.303895 ↗
81. Zacchigna, S. et al. Paracrine effect of regulatory T cells promotes cardiomyocyte proliferation during pregnancy and after myocardial infarction. Nat. Commun. 9, 2432 (2018).10.1038/s41467-018-04908-z ↗
82. Bao, R. et al. A π-π conjugation-containing soft and conductive injectable polymer hydrogel highly efficiently rebuilds cardiac function after MI. Biomaterials 122, 63–71 (2017).10.1016/j.biomaterials.2017.01.012 ↗
83. Wang, L. L. et al. Mussel-inspired conductive cryogel as cardiac tissue patch to repair MI by migration of conductive nanoparticles. Adv. Funct. Mater. 26, 4293–4305 (2016).10.1002/adfm.201505372 ↗
84. Hsiao, C. W. et al. Electrical coupling of isolated cardiomyocyte clusters grown on aligned conductive nanofibrous meshes for their synchronized beating. Biomaterials 34, 1063–1072 (2013).10.1016/j.biomaterials.2012.10.065 ↗
85. Song, X. P. et al. A tunable self-healing ionic hydrogel with microscopic homogeneous conductivity as a cardiac patch for MI repair. Biomaterials 273, 120811 (2021).10.1016/j.biomaterials.2021.120811 ↗
86. Qazi, T. H., Rai, R. & Boccaccini, A. R. Tissue engineering of electrically responsive tissues using polyaniline based polymers: a review. Biomaterials 35, 9068–9086 (2014).10.1016/j.biomaterials.2014.07.020 ↗
87. Kai, D., Prabhakaran, M. P., Jin, G. & Ramakrishna, S. Polypyrrole-contained electrospun conductive nanofibrous membranes for cardiac tissue engineering. J. Biomed. Mater. Res. A 99, 376–385 (2011).10.1002/jbm.a.33200 ↗
88. Navaei, A. et al. Gold nanorod-incorporated gelatin-based conductive hydrogels for engineering cardiac tissue constructs. Acta Biomater. 41, 133–146 (2016).10.1016/j.actbio.2016.05.027 ↗
89. Pok, S. et al. Biocompatible carbon nanotube-chitosan scaffold matching the electrical conductivity of the heart. ACS Nano 8, 9822–9832 (2014).10.1021/nn503693h ↗
90. Mihic, A. et al. A conductive polymer hydrogel supports cell electrical signaling and improves cardiac function after implantation into myocardial infarct. Circulation 132, 772–784 (2015).10.1161/CIRCULATIONAHA.114.014937 ↗
91. Wang, W. et al. An injectable conductive hydrogel encapsulating plasmid DNA-eNOs and ADSCs for treating MI. Biomaterials 160, 69–81 (2018).10.1016/j.biomaterials.2018.01.021 ↗
92. Liang, S. et al. Paintable and rapidly bondable conductive hydrogels as therapeutic cardiac patches. Adv. Mater. 30, 1704235 (2018).10.1002/adma.201704235 ↗
93. He, S. et al. The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failure. Biomaterials 258, 120285 (2020).10.1016/j.biomaterials.2020.120285 ↗
94. Motealleh, A. & Kehr, N. S. Nanocomposite hydrogels and their applications in tissue engineering. Adv. Healthc. Mater. 6, 1600938 (2017).10.1002/adhm.201600938 ↗
95. Lei, Z. Y. & Wu, P. Y. A highly transparent and ultra-stretchable conductor with stable conductivity during large deformation. Nat. Commun. 10, 3429 (2019).10.1038/s41467-019-11364-w ↗
96. Noshadi, I. et al. Engineering biodegradable and biocompatible bio-ionic liquid conjugated hydrogels with tunable conductivity and mechanical properties. Sci. Rep. 7, 4345 (2017).10.1038/s41598-017-04280-w ↗
97. Liu, Y. et al. One zwitterionic injectable hydrogel with ion conductivity enables efficient restoration of cardiac function after MI. Chem. Eng. J. 418, 129352 (2021).10.1016/j.cej.2021.129352 ↗
98. Zhao, Q. & Li, Z. J. Angiogenesis. BioMed. Res. Int. 2015, 135861 (2015).
99. Awada, H. K., Johnson, N. R. & Wang, Y. D. Sequential delivery of angiogenic growth factors improves revascularization and heart function after MI. J. Control. Release 207, 7–17 (2015).10.1016/j.jconrel.2015.03.034 ↗
100. Yuan, Z. Z. et al. Injectable citrate-based hydrogel as an angiogenic biomaterial improves cardiac repair after MI. ACS Appl. Mater. Interfaces 11, 38429–38439 (2019).10.1021/acsami.9b12043 ↗